Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

NCT00263705 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT00263705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
August 31, 2009
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, elderly patients